Page 5 - Development Fellowship News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Background Governments commonly fund research with specific applications in mind. Such mechanisms may facilitate ‘research translation’ but funders may employ strategies that can also undermine the integrity of both science and government. We estimated the prevalence and investigated correlates of funder efforts to suppress health behaviour intervention trial findings. Methods Our sampling frame was lead or corresponding authors of papers (published 2007–2017) included in a Cochrane review, reporting findings from trials of interventions to improve nutrition, physical activ...

SOPORE Masarat Kar, one of the NC councillors from Sopore talking to the media before the start of the meeting on May 29, 2021. When they were in the meeting, two of the members and a cop were killed in a militant attack. National Conference (NC) finally got the leadership of Sopore Municipal Council after Masarat Kar – the daughter of Ghulam Rasool Kar, defeated PDP by polling 12 of the 18 votes. The position was vacant since January 2021.  The council was the target of a surprise attack by militants in March in which two councillors and a cop were killed. Jammu Kashmir Police received ar...

Jon Adams is Distinguished Professor of Public Health, Director of the Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) and Deputy Head of School (Research) at the School of Public Health, UTS. Jon also holds a number of national and international leadership positions/appointments with leading associations such as the PHAA and APHA and he has led work commissioned by a range of Health Ministries/Dept of Health and the World Health Organization amongst others. Professor Adams is the world-leading public health and health services researcher focused upon self-care, ...

Share A national clinical trial program will test promising new targeted therapies for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia. The clinical trial program (MoST–P), led by researchers and clinicians at UNSW and the Garvan Institute, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment. UNSW Dean of Medicine & Health, Professor Vlado Perkovic said the grant could lead to better outcomes for pancreatic c...

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute...